Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074201 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP
A NA study of Choledocholithiasis and Biliary Obstruction, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03074201 is a NA study of Choledocholithiasis and Biliary Obstruction that has completed, run by Stanford University. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03074201, a NA study of Choledocholithiasis and Biliary Obstruction, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.
Conditions Studied
Interventions
- PROCEDURE Cholangioscopy
- DEVICE Spyglass DS Cholangioscope
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2017-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03074201
The ClinicalTrials.gov registry entry for NCT03074201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Choledocholithiasis appearing as the primary indexed condition, and to 2 interventions - of which Cholangioscopy is the first listed.
NCT03074201 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03074201 about?
NCT03074201 is a clinical study titled "Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP". Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.
What is the current status of trial NCT03074201?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-10-01. Estimated completion is 2017-05-20.
What conditions does trial NCT03074201 study?
This clinical trial studies the following conditions: Choledocholithiasis, Biliary Obstruction.
What interventions are being tested in trial NCT03074201?
The interventions under investigation include: Cholangioscopy (PROCEDURE), Spyglass DS Cholangioscope (DEVICE).
Who is sponsoring clinical trial NCT03074201?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03074201 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Choledocholithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.